Japanese startup QD Laser, the developer of retinal scanning displays called the Retissa series, announced on Monday that IPO application to the Tokyo Stock Exchange (TSE) has been approved. The company will be listed on the TSE Mothers Market on February 5 of 2021 with plans to offer 9,451,800 shares for public subscription and to sell 2,033,900 shares in over-allotment options for a total of 4,107,600 shares. The underwriting will be led by SMBC Nikko securities while QD Laser’s ticker code will be 6613.
Based on the estimated issue price of 275 yen (about $2.65), the company will be valued at 9.51 billion yen (about $91.7 million). Its share price range will be released on January 20 with bookbuilding scheduled to start on January 21 and pricing on January 27. According to the consolidated statement as of March 2020, they posted revenue of 756.63 million yen ($7.3 million) with an ordinary loss of 1.23 billion yen ($11.8 million).
QD Laser was established in 2006 as a spin-off from Fujitsu Laboratories where QD Laser’s founder and CEO Mitsuru Sugawara was previously quantum dot lasers. Using the company’s technology, images can be directly delivered onto the device wearer’s retina from a laser projector built inside the frame, and has the potential to improve the quality of life (QoL) of the visually impaired who are not totally blind but are forced to live in a blurred world. It is also expected to be applied to augmented reality and smart glasses.
Led by Japanese computer manufacturing giant Fujitsu (26.64% through their three funds, TSE:6702), the company’s major shareholders include Tokyo Century (TSE:8439, 13.02%), Mitsui & Co. Global Investment (12.45%), Axa Life Insurance (6.80%), QD Laser’s Sugawara (5.17%), Beyond Next Ventures (2.67%), Daiichi Life Insurance, Realtech Fund (2.66%), DG Ventures (2.36%), and Nikko-SBI Innovation Fund (2.36%).